Connection

Robert Haile to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications Robert Haile has written about Breast Neoplasms.
Robert Haile
Connection Strength
2.268
Breast Neoplasms
  1. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1863-70.
    View in: PubMed
    Score: 0.139
  2. Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2829-39.
    View in: PubMed
    Score: 0.131
  3. Breast cancer risks for BRCA1/2 carriers. Science. 2004 Dec 24; 306(5705):2187-91; author reply 2187-91.
    View in: PubMed
    Score: 0.123
  4. Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer. JAMA Netw Open. 2019 09 04; 2(9):e1912259.
    View in: PubMed
    Score: 0.085
  5. Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry. BMC Cancer. 2018 May 05; 18(1):532.
    View in: PubMed
    Score: 0.077
  6. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study. J Natl Cancer Inst. 2017 10 01; 109(10).
    View in: PubMed
    Score: 0.074
  7. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Res. 2017 Jul 19; 19(1):83.
    View in: PubMed
    Score: 0.073
  8. Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. Cancer Res. 2016 09 01; 76(17):5103-14.
    View in: PubMed
    Score: 0.067
  9. Risk of breast cancer among patients with bioprosthetic or mechanical valve replacement: a population-based study in Sweden. Breast Cancer Res Treat. 2015 Nov; 154(2):369-75.
    View in: PubMed
    Score: 0.065
  10. A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):658-69.
    View in: PubMed
    Score: 0.058
  11. Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1547-56.
    View in: PubMed
    Score: 0.055
  12. Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes Control. 2013 Aug; 24(8):1605-14.
    View in: PubMed
    Score: 0.055
  13. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. Eur J Cancer. 2013 Sep; 49(14):2979-85.
    View in: PubMed
    Score: 0.055
  14. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol. 2013 Feb 01; 31(4):433-9.
    View in: PubMed
    Score: 0.053
  15. Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population. Cancer Epidemiol Biomarkers Prev. 2012 Dec; 21(12):2261-7.
    View in: PubMed
    Score: 0.053
  16. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst. 2012 Sep 19; 104(18):1363-72.
    View in: PubMed
    Score: 0.052
  17. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2012 Nov 15; 84(4):917-24.
    View in: PubMed
    Score: 0.051
  18. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Breast Cancer Res. 2011; 13(6):R114.
    View in: PubMed
    Score: 0.049
  19. Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Hum Mutat. 2012 Jan; 33(1):158-64.
    View in: PubMed
    Score: 0.049
  20. Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Res Treat. 2012 Jan; 131(2):571-80.
    View in: PubMed
    Score: 0.049
  21. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat. 2011 Nov; 130(2):587-97.
    View in: PubMed
    Score: 0.048
  22. Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling. Genet Epidemiol. 2011 Jul; 35(5):389-97.
    View in: PubMed
    Score: 0.048
  23. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status. Breast Cancer Res Treat. 2011 Jun; 127(3):819-29.
    View in: PubMed
    Score: 0.046
  24. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 May 10; 28(14):2404-10.
    View in: PubMed
    Score: 0.044
  25. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst. 2010 Apr 07; 102(7):475-83.
    View in: PubMed
    Score: 0.044
  26. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010 Apr 01; 16(7):2214-24.
    View in: PubMed
    Score: 0.044
  27. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat. 2010 Mar; 31(3):E1200-40.
    View in: PubMed
    Score: 0.044
  28. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2):491-8.
    View in: PubMed
    Score: 0.044
  29. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control. 2010 Jun; 21(6):839-46.
    View in: PubMed
    Score: 0.044
  30. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Res Treat. 2010 Feb; 120(1):175-83.
    View in: PubMed
    Score: 0.042
  31. Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol. 2009 Apr 15; 169(8):962-8.
    View in: PubMed
    Score: 0.041
  32. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res. 2008 Aug 15; 68(16):6486-91.
    View in: PubMed
    Score: 0.039
  33. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):1021-30.
    View in: PubMed
    Score: 0.039
  34. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group. J Clin Oncol. 2008 Mar 20; 26(9):1411-8.
    View in: PubMed
    Score: 0.038
  35. Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008 Jan 09; 299(2):194-201.
    View in: PubMed
    Score: 0.038
  36. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study. J Natl Cancer Inst. 2008 Jan 02; 100(1):32-40.
    View in: PubMed
    Score: 0.038
  37. Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiol Biomarkers Prev. 2007 May; 16(5):906-11.
    View in: PubMed
    Score: 0.036
  38. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1565-7.
    View in: PubMed
    Score: 0.034
  39. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res. 2004; 6(3):R199-214.
    View in: PubMed
    Score: 0.029
  40. Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat. 2003 May; 21(5):542-50.
    View in: PubMed
    Score: 0.027
  41. Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J Clin Oncol. 2018 01 01; 36(1):25-33.
    View in: PubMed
    Score: 0.019
  42. Determining the familial risk distribution of colorectal cancer: a data mining approach. Fam Cancer. 2016 Apr; 15(2):241-51.
    View in: PubMed
    Score: 0.017
  43. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst. 2013 Feb 20; 105(4):274-9.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.